SCHEDULE 3U.K.Consequential Amendments

National Health Service (Pharmaceutical Services) (Wales) Regulations 2013U.K.

10.  In the National Health Service (Pharmaceutical Service) (Wales) Regulations 2013 M1

(a)in the English language text, in regulation 2(1) (interpretation), for the definition “advanced electronic signature”, substitute—

advanced electronic signature” means an advanced electronic signature as defined in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;; and

(b)in the Welsh language text, in regulation 2(1) (Dehongli), for the definition “llofnod electronig uwch”, substitute—

ystyr “llofnod electronig uwch” yw llofnod electronic uwch fel y'i diffinir yn Erthygl 3(11) o Reoliad (EU) Rhif 910/2014 Senedd Ewrop a'r Cyngor ar adnabod electronig a gwasanaethau ymddiried ar gyfer trafodiadau electronig yn y farchnad fewnol;.

Marginal Citations

M1S.I. 2013/898 (W.102). The Regulations are made in Welsh and English. By virtue of section 156(1) of the Government of Wales Act 2006 (c.32) the English and Welsh texts are to be treated for all purposes as being of equal standing. The title of the Regulations in Welsh is Rheoliadau'r Gwasanaeth Iechyd Gwladol (Gwasanaethau Fferyllol) (Cymru) 2013.